4/8/19 16:15 | 4/8/19 | PSTI | Pluristem Therapeutics Inc | NV | Health | BioPrd | Biological Products, (No Diag | Yanay Yaky | L3 | DO | Co-CEO,P | P.d | 50 | 0.7000 | 0 | 71 | 2 | 4,320 | D | | | | | | | | | | | | | | |
2/22/16 16:02 | 2/18/16 | PSTI | Pluristem Therapeutics Inc | NV | Health | BioPrd | Biological Products, (No Diag | Yanay Yaky | L3 | DO | CFO,COO, | P | 6 | 1.20 | 0 | 5 | 0 | 1,518 | I | -69 | -58 | -41 | -18 | 24 | 42 | 64 | 18 | -4 | -7 | 24 | 6 | 32 | -16 |
2/17/16 16:01 | 2/16/16 | PSTI | Pluristem Therapeutics Inc | NV | Health | BioPrd | Biological Products, (No Diag | Yanay Yaky | L3 | DO | CFO,COO, | P | 14 | 0.9500 | 0 | 15 | 1 | 1,513 | I | -74 | -64 | -52 | -31 | -6 | 22 | 20 | 33 | 0 | 0 | 20 | 27 | 29 | -17 |
2/16/16 16:10 | 2/12/16 | PSTI | Pluristem Therapeutics Inc | NV | Health | BioPrd | Biological Products, (No Diag | Yanay Yaky | L3 | DO | CFO,COO, | P | 4 | 0.8277 | 0 | 5 | 0 | 1,498 | I | -80 | -72 | -63 | -48 | -28 | -8 | -4 | 7 | 22 | 35 | 65 | 65 | 60 | 10 |
11/17/15 07:38 | 11/16/15 | PSTI | Pluristem Therapeutics Inc | NV | Health | BioPrd | Biological Products, (No Diag | Yanay Yaky | L3 | DO | CFO,COO, | P | 15 | 1.52 | 0 | 10 | 1 | 1,343 | I | -54 | -46 | -45 | -30 | -15 | -8 | -13 | -3 | 1 | -3 | -30 | -15 | 1 | 3 |
9/21/15 16:09 | 9/21/15 | PSTI | Pluristem Therapeutics Inc | NV | Health | BioPrd | Biological Products, (No Diag | Yanay Yaky | L3 | DO | CFO,COO, | P | 21 | 2.11 | 0 | 10 | 1 | 1,333 | I | -37 | -28 | -25 | -22 | -2 | 6 | 7 | -2 | -2 | -6 | -14 | -45 | -20 | -21 |
9/17/15 09:25 | 9/16/15 | PSTI | Pluristem Therapeutics Inc | NV | Health | BioPrd | Biological Products, (No Diag | Yanay Yaky | L3 | DO | COO,CFO, | P | 21 | 2.12 | 0 | 10 | 1 | 1,323 | I | -38 | -24 | -27 | -22 | -8 | 9 | 12 | 2 | 0 | -6 | -16 | -52 | -30 | -22 |
11/12/14 08:14 | 11/11/14 | PSTI | Pluristem Therapeutics Inc | NV | Health | BioPrd | Biological Products, (No Diag | Yanay Yaky | L3 | O | COO,P | P | 29 | 2.62 | 0 | 11 | 1 | 1,113 | D | -19 | -21 | -25 | 0 | -4 | -11 | -11 | -5 | 1 | 2 | -1 | 11 | 3 | -40 |
9/23/14 10:53 | 9/22/14 | PSTI | Pluristem Therapeutics Inc | NV | Health | BioPrd | Biological Products, (No Diag | Yanay Yaky | L3 | O | COO,P | P | 32 | 2.95 | 0 | 11 | 1 | 1,091 | D | -27 | -14 | -24 | -10 | 6 | 1 | 4 | -3 | 2 | 1 | 3 | -13 | 5 | -30 |
9/16/14 16:25 | 9/16/14 | PSTI | Pluristem Therapeutics Inc | NV | Health | BioPrd | Biological Products, (No Diag | Yanay Yaky | L3 | O | COO,P | P | 29 | 2.85 | 0 | 10 | 1 | 1,080 | D | -42 | -16 | -32 | -16 | -2 | 2 | -6 | -5 | 6 | 3 | 4 | -8 | 3 | -24 |
1/14/14 16:11 | 1/10/14 | PSTI | Pluristem Therapeutics Inc | NV | Health | BioPrd | Biological Products, (No Diag | Yanay Yaky | L3 | O | CFO,EVP | S.m | -300 | 4.29 | 2 | -70 | -6 | 1,070 | D | 61 | 32 | 43 | 28 | 32 | 33 | 15 | 3 | -1 | -4 | -7 | -22 | -30 | -34 |
1/9/14 18:06 | 1/8/14 | PSTI | Pluristem Therapeutics Inc | NV | Health | BioPrd | Biological Products, (No Diag | Yanay Yaky | L3 | O | CFO,EVP | S.m | -128 | 4.25 | 1 | -30 | -3 | 1,139 | D | 62 | 29 | 37 | 32 | 30 | 25 | 28 | 18 | 0 | 2 | -6 | -11 | -30 | -33 |
8/21/12 16:05 | 8/17/12 | PSTI | Pluristem Therapeutics Inc | NV | Health | BioPrd | Biological Products, (No Diag | Yanay Yaky | L3 | O | CFO | S | -85 | 5.00 | 7 | -17 | -2 | 770 | D | 292 | 63 | 54 | 51 | 58 | 15 | -1 | -7 | -1 | -5 | -1 | -25 | -21 | -24 |
1/20/11 09:44 | 1/18/11 | PSTI | Pluristem Therapeutics Inc | NV | Health | BioPrd | Biological Products, (No Diag | Yanay Yaky | L3 | O | CFO | S | -48 | 3.20 | 2 | -15 | -4 | 387 | D | 362 | 153 | 153 | 98 | 95 | 87 | 56 | 2 | -13 | 44 | -8 | 1 | 19 | -9 |
1/13/11 08:32 | 1/11/11 | PSTI | Pluristem Therapeutics Inc | NV | Health | BioPrd | Biological Products, (No Diag | Yanay Yaky | L3 | O | CFO | S | -26 | 2.60 | 1 | -10 | -2 | 402 | D | 306 | 122 | 140 | 83 | 90 | 62 | 71 | 42 | 8 | -4 | 11 | 18 | 26 | 2 |
6/15/07 11:38 | 5/24/07 | PLRS | Pluristem Life Systems Inc | NV | Health | BioPrd | Biological Products, (No Diag | Yanay Yaky | L3 | O | CFO | P.ad | 50 | 0.0125 | 0 | 4,000 | New | 4,000 | D | | | | | | | | | | | | | | |